Home » Topics » BioWorld Science

BioWorld Science
RSS

h11B11, a potent hACE2-targeting MAb against SARS-CoV-2 variants

Sep. 21, 2021

Complement C5 inhibitor RA-101295 protects against hemolytic anemia and kidney injury in baboons

Sep. 21, 2021

Novel malaria vaccine candidate developed using recombinant SAMSP1 mosquito saliva protein

Sep. 21, 2021

New HIV replication inhibitors discovered at Gilead

Sep. 21, 2021

Remix Therapeutics patents RNA splicing modulators

Sep. 21, 2021

New PBP3 ligands identified at Bicycletx

Sep. 21, 2021

UCB describes new IL-17 modulators

Sep. 21, 2021

PF-06873600 disrupts cell-cycle progression and shows antitumor activity in vivo

Sep. 21, 2021

Exosome-mediated transcellular delivery of SIRT2 modulates ATP homeostasis within axons

Sep. 21, 2021

BET protein inhibition can reverse CAR T-cell exhaustion

Sep. 20, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...